StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3046% below fair value
$24.66−0.19 (-0.76%)

Close on Nov 13, 2026Market cap $678.53MP/E –Yield –

Fulgent Genetics gross margin

Gross margin is gross profit as a percentage of revenue.

Fulgent Genetics's gross margin for the twelve months ending Sep 30, 2026 was 33.8%. For fiscal 2025 it was 40.6%, against 37.8% the year before. The highest annual figure on record is 78.7% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202540.6%+2.7
FY2024Dec 31, 202437.8%+1.7
FY2023Dec 31, 202336.1%−23.2
FY2022Dec 31, 202259.3%−19.0
FY2021Dec 31, 202178.3%−0.4
FY2020Dec 31, 202078.7%+22.1
FY2019Dec 31, 201956.6%+6.7
FY2018Dec 31, 201849.9%−4.4
FY2017Dec 31, 201754.3%−8.9
FY2016Dec 31, 201663.2%+16.2
FY2015Dec 31, 201547.1%+20.3
FY2014Dec 31, 201426.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202635.3%−6.9
Q2 FY2026Jun 30, 202630.1%−12.0
Q1 FY2026Mar 31, 202630.2%−8.4
Q4 FY2025Dec 31, 202539.1%−2.7
Q3 FY2025Sep 30, 202542.2%+4.9
Q2 FY2025Jun 30, 202542.1%+4.8
Q1 FY2025Mar 31, 202538.6%+4.3
Q4 FY2024Dec 31, 202441.8%+6.0
Q3 FY2024Sep 30, 202437.3%−9.7
Q2 FY2024Jun 30, 202437.3%+7.0
Q1 FY2024Mar 31, 202434.3%+5.8
Q4 FY2023Dec 31, 202335.8%+16.6
Q3 FY2023Sep 30, 202347.0%+3.4
Q2 FY2023Jun 30, 202330.3%−21.8
Q1 FY2023Mar 31, 202328.4%−47.3
Q4 FY2022Dec 31, 202219.2%−56.1
Q3 FY2022Sep 30, 202243.6%−37.3
Q2 FY2022Jun 30, 202252.1%−24.6
Q1 FY2022Mar 31, 202275.7%−3.7
Q4 FY2021Dec 31, 202175.3%−7.1
Q3 FY2021Sep 30, 202180.9%+6.7
Q2 FY2021Jun 30, 202176.7%+21.4
Q1 FY2021Mar 31, 202179.4%+31.7
Q4 FY2020Dec 31, 202082.4%+25.8
Q3 FY2020Sep 30, 202074.2%+11.7
Q2 FY2020Jun 30, 202055.3%−1.7
Q1 FY2020Mar 31, 202047.7%+2.9
Q4 FY2019Dec 31, 201956.7%+5.5
Q3 FY2019Sep 30, 201962.5%+8.9
Q2 FY2019Jun 30, 201957.0%+4.1
Q1 FY2019Mar 31, 201944.7%+4.3
Q4 FY2018Dec 31, 201851.2%+10.6
Q3 FY2018Sep 30, 201853.6%+3.9
Q2 FY2018Jun 30, 201852.9%−6.6
Q1 FY2018Mar 31, 201840.4%−24.5
Q4 FY2017Dec 31, 201740.6%−27.6
Q3 FY2017Sep 30, 201749.6%–
Q2 FY2017Jun 30, 201759.5%–
Q1 FY2017Mar 31, 201765.0%–
Q4 FY2016Dec 31, 201668.2%–

More Fulgent Genetics figures

See a number that looks wrong?